from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2135c/-

LFCtreatmentdescriptionclass of inhibitor

-0.490

Amikacinug/mL Amikacintranslation

-0.600

Cap5-10ug/mL Capreomycintranslation

1.367

Rox10-50 ug/mL Roxithromycintranslation

-0.708

SM2-5 ug/mL Streptomycintranslation

-1.883

Tet5-10 ug/mL Tetracyclinetranslation

0.181

Rif0.2-5ug/mL Rifampicintranscription

-0.472

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.895

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.059

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.041

CPZ10-50 ug/mL Chlorpromazinerespiration

0.905

Clofazimine10-13 ug/mL Clofaziminerespiration

0.588

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.188

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.831

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.257

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.577

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.067

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.393

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.543

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.028

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.459

KCN5-20 ug/mL Potassium cyaniderespiration

0.075

NaN30.2-2 mM Sodium aziderespiration

0.159

Nigericin50 uM Nigericinrespiration

-0.972

TRC10-150 ug/mL Triclosanrespiration

-0.171

TRZ10-25 ug/mL Thioridazinerespiration

-1.505

Valinomycin0.5-10 uM Valinomycinrespiration

1.291

ZnSO42 mM ZnSO4respiration

-0.980

menadione6-10 ug/mL Menadionerespiration

0.728

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.119

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.047

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.073

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.255

NRP_1Non-replicating persistence stage 1dosRassociated

0.273

Amp0.2mg/mL AmpicillincellWall

0.252

Cephalexin20-100 ug/mL CephalexincellWall

-0.400

Cerulenin0.32-5 ug/mL CerulenincellWall

0.202

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.171

EMB10-20 ug/mL EthambutolcellWall

0.344

Eta12-40 ug/mL EthionamidecellWall

0.428

INH0.2-0.4 ug/mL IsoniazidcellWall

0.443

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.466

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.630

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.105

BZA0.12 mg/mL BenzamidearomaticAmides

-0.415

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.279

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.108

H2O24 mM hydrogen peroxideDNAdamaging

-0.075

Levo10 ug/mL LevofloxacinDNAdamaging

-0.895

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.056

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.697

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.591

UVUV-irradiationDNAdamaging

0.276

ARP41-4 ug/mL Antitubercular compound ARP4?

0.105

Antimycin12.5-50 ug/mL Antimycin A?

0.150

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.276

PA_110-50 ug/mL Antitubercular compound PA-1?

0.450

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.709

PA8240.2-2 ug/mL PA-824?

-0.096

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.250

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.916

Verapamil50 uM Verapamil?

-0.031

mercaptoethanol2 mM 2-Mercaptoethanol?

0.573

methoxatin10-20 ug/mL Methoxatin?